Liang, Shaoheng
Willis, Jason
Dou, Jinzhuang
Mohanty, Vakul
Huang, Yuefan
Vilar, Eduardo
Chen, Ken
Article History
Received: 19 June 2021
Accepted: 13 December 2021
First Online: 4 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Vilar has a consulting and advisory role with Janssen Research and Development, and Recursion Pharma. The rest of the authors declare that they have no competing interests.